Study Details
A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients with Rheumatoid Arthritis taking Methotrexate
Clinicaltrials.gov ID
Astellas Study ID
1707-CL-3001
EudraCT ID
N/A
Condition
Rheumatoid Arthritis
Phase
Phase 2
Age
N/A - N/A
Sex
Female
Product
N/A
Type
Interventional
Trial Dates
Sep 2016 - Oct 2017
Masking
Double (Participant, Investigator)
Enrollment number
72
Phase IIa Study of ASP1707 A Randomized, Placebo-Controlled, Double-Blind, Parallel Group Phase 2a Study of ASP1707 in Postmenopausal Female Patients with Rheumatoid Arthritis (RA) taking Methotrexate (MTX)
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients with Rheumatoid Arthritis taking Methotrexate? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site JP00014
Kumamoto, Japan
Site JP00021
Kanagawa, Japan
Site JP00027
Tokyo, Japan
Site JP00002
Hokkaido, Japan
Site JP00015
Kumamoto, Japan
Site JP00025
Fukui, Japan
Site JP00004
Iwate, Japan
Site JP00024
Gunma, Japan
Site JP00022
Aichi, Japan
Site JP00001
Hokkaido, Japan
Site JP00020
Oita, Japan
Site JP00010
Hiroshima, Japan
Site JP00008
Shizuoka, Japan
Site JP00017
Chiba, Japan
Site JP00003
Hokkaido, Japan
Site JP00009
Shizuoka, Japan
Site JP00007
Kanagawa, Japan
Site JP00006
Gunma, Japan
Site JP00016
Kagoshima, Japan
Site JP00018
Fukuoka, Japan
Site JP00013
Nagasaki, Japan
Site JP00012
Fukuoka, Japan
Site JP00023
Aichi, Japan
Site JP00011
Hiroshima, Japan
Site JP00019
Fukuoka, Japan
Site JP00026
Ehime, Japan
Site JP00005
Iwate, Japan